- Home
- ACN vs JNJ Comparison
ACN vs JNJ Comparison
Compare ACN & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACN | JNJ |
|---|---|---|
| Founded | 1989 | 1886 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.6B | 505.3B |
| IPO Year | N/A | 1944 |
Fundamental Metrics
Financial Performance| Metric | ACN | JNJ |
|---|---|---|
| Price | $286.68 | $218.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 15 |
| Target Price | ★ $301.41 | $209.27 |
| AVG Volume (30 Days) | 4.0M | ★ 7.9M |
| Earning Date | 12-18-2025 | 01-21-2026 |
| Dividend Yield | 2.28% | ★ 2.38% |
| EPS Growth | 1.33 | ★ 71.26 |
| EPS | ★ 12.09 | 10.35 |
| Revenue | $70,725,557,000.00 | ★ $92,149,000,000.00 |
| Revenue This Year | $7.07 | $6.63 |
| Revenue Next Year | $5.39 | $5.49 |
| P/E Ratio | $23.68 | ★ $21.13 |
| Revenue Growth | ★ 6.58 | 5.08 |
| 52 Week Low | $229.40 | $141.50 |
| 52 Week High | $398.35 | $220.11 |
Technical Indicators
Market Signals| Indicator | ACN | JNJ |
|---|---|---|
| Relative Strength Index (RSI) | 64.48 | 68.78 |
| Support Level | $273.00 | $203.85 |
| Resistance Level | $291.09 | $208.98 |
| Average True Range (ATR) | 8.17 | 3.44 |
| MACD | 1.06 | 1.16 |
| Stochastic Oscillator | 86.67 | 91.46 |
Price Performance
Historical ComparisonAbout ACN Accenture plc (Ireland)
Accenture is a leading IT services firm that provides consulting, system integration, and business process outsourcing to enterprises around the world. Customers of Accenture come from a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture is the world's largest professional services company by headcount with around 800,000 employees in over 120 countries.
About JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.